These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3409399)
41. Studies on the promoting effects of carboxylic acid derivatives on the rectal absorption of beta-lactam antibiotics in rats. Nishimura K; Nozaki Y; Yoshimi A; Nakamura S; Kitagawa M; Kakeya N; Kitao K Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):282-91. PubMed ID: 4006019 [No Abstract] [Full Text] [Related]
42. Effects of hypolipidemic drugs on hepatic CoA. Halvorsen O Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659 [No Abstract] [Full Text] [Related]
43. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter. Kramer W; Glombik H; Petry S; Heuer H; Schäfer H; Wendler W; Corsiero D; Girbig F; Weyland C FEBS Lett; 2000 Dec; 487(2):293-7. PubMed ID: 11150527 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of hepatic gluconeogenesis and lipogenesis by benzoic acid, p-tert.-butylbenzoic acid, and a structurally related hypolipidemic agent SC-33459. McCune SA; Durant PJ; Flanders LE; Harris RA Arch Biochem Biophys; 1982 Mar; 214(1):124-33. PubMed ID: 7081992 [No Abstract] [Full Text] [Related]
45. Hypolipidemic action of onion and garlic unsaturated oils in sucrose fed rats over a two-month period. Adamu I; Joseph PK; Augusti KT Experientia; 1982 Aug; 38(8):899-901. PubMed ID: 7128726 [No Abstract] [Full Text] [Related]
46. Effect of polyol detergents on cholesterol and triglyceride absorption. Hypolipidemic action of chronic administration of hydrophobic detergent. Bochenek WJ; Rodgers JB Biochim Biophys Acta; 1977 Dec; 489(3):503-6. PubMed ID: 588583 [TBL] [Abstract][Full Text] [Related]
47. Effect of hypolipidemic drugs on the metabolism of lauric acid and dimethylaminoazobenzene by rat liver microsomes. Raza H; Levine WG Biochem Pharmacol; 1987 Mar; 36(5):774-8. PubMed ID: 3103631 [No Abstract] [Full Text] [Related]
48. [The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines]. Ryzhenkov VE; Chistiakova AM; Okunevich IV Patol Fiziol Eksp Ter; 1989; (5):16-9. PubMed ID: 2616207 [TBL] [Abstract][Full Text] [Related]
49. Combined lipid lowering drug therapy for the effective treatment of hypercholesterolaemia. Shepherd J Eur Heart J; 2003 Apr; 24(8):685-9. PubMed ID: 12713763 [No Abstract] [Full Text] [Related]
50. Additional proof of reduction of ethanol absorption from rat intestine in vivo by high acetaldehyde concentrations. Kinoshita H; Ijiri I; Ameno S; Fuke C; Ameno K Alcohol Alcohol; 1995 Jul; 30(4):419-21. PubMed ID: 8540907 [TBL] [Abstract][Full Text] [Related]
51. Hypolipidemic activity of Tamarix articulata Vahl. in diabetic rats. Hebi M; Eddouks M J Integr Med; 2017 Nov; 15(6):476-482. PubMed ID: 29103418 [TBL] [Abstract][Full Text] [Related]
52. Guidelines for methods to determine efficacy and safety of drugs acting on the gastrointestinal tract. The international union of pharmacology (IUPHAR). Kesäniemi YA Am J Cardiol; 1998 Apr; 81(8A):27F-28F. PubMed ID: 9604901 [No Abstract] [Full Text] [Related]
53. Experimental investigation of hypolipidemic and anti-atherosclerotic drugs with different mechanism of action. Klimov AN; Ryzhenkov VE; Petrova LA; Polyakova ED Adv Exp Med Biol; 1977; 82():477-82. PubMed ID: 920403 [No Abstract] [Full Text] [Related]
54. Effect of 4-(4'-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats. Okada K; Yagasaki K; Mochizuki T; Takagi K; Irikura T Biochem Pharmacol; 1985 Sep; 34(18):3361-7. PubMed ID: 4038342 [TBL] [Abstract][Full Text] [Related]
55. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs. Ciriolo MR; Mavelli I; Rotilio G; Borzatta V; Cristofari M; Stanzani L FEBS Lett; 1982 Aug; 144(2):264-8. PubMed ID: 7117540 [No Abstract] [Full Text] [Related]
56. Studies on hypolipidemic agents. III. Synthesis and esterase-inhibitory activity of omega-cycloalkyl-2-oxoalkyl arenesulfonates. Ogawa K; Terada T; Muranaka Y; Hamakawa T; Fujii S Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2426-36. PubMed ID: 3664839 [No Abstract] [Full Text] [Related]
57. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones. Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157 [TBL] [Abstract][Full Text] [Related]
58. Newer hypolipidemic compounds. Kritchevsky D Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139 [No Abstract] [Full Text] [Related]
59. Studies on hypolipidemic agents. IV. Syntheses and biological activities of trans- and cis-2-(4-alkylcyclohexyl)-2-oxoethyl arenesulfonates. Ogawa K; Terada T; Muranaka Y; Hamakawa T; Ohta S; Okamoto M; Fujii S Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3276-83. PubMed ID: 3427711 [No Abstract] [Full Text] [Related]
60. Interrelated effects of dietary fiber and fat on lymphatic cholesterol and triglyceride absorption in rats. Ikeda I; Tomari Y; Sugano M J Nutr; 1989 Oct; 119(10):1383-7. PubMed ID: 2555465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]